Ogenx Therapeutics Corporation - Partners Ogenx Therapeutics Corporation - Partners
Ogenx Logo

Industry Partners:

Click on the company name to view more information.


Regulatory and Clinical Development

The Company's primary objective is to maximize excellence, reduce overhead, and minimize cash requirements as we complete our objectives. One means of achieving these goals is through the formation of a strategic alliance with a clinical research organization that has the global resources, reputation and ability to conduct our clinical development programs worldwide. The Company has entered into the first of a series of agreements with Quintiles - the world's largest CRO, to form what is anticipated will become a strategic alliance for the entire Redoxagen Technology portfolio. Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. Their network of more than 25,000 professionals operate in 60 countries and deliver results with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies develop and commercialize products to improve and lengthen patients' lives while demonstrating value to stakeholders.


Preclinical, Toxicology, Bioanalytics

Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies, with annual revenues greater than $2 billion, employees in more than 60 countries, and more than 11,000 employees worldwide. For more than 50 years Covance has helped our clients make fast and effective drug development decisions. Our comprehensive suite of nonclinical drug development services provides continuity as candidates go through the drug development process. Operational excellence, outstanding customer service and the highest quality data make Covance a leading choice for outsourced nonclinical development needs around the world.


cGMP Manufacturing, CMC

PharmaCore is a leader in fostering the commercial development of small molecule drug discovery and development in pharmaceutical, discovery platform, and biotechnology companies. The PharmaCore offering parallels the drug discovery process and provides significant advantages at each step from lead discovery to lead optimization, chemical synthesis and scale-up of pharmaceutical intermediates as well as chemical process R&D.


CMC Fill&Finish, Storage, Distribution

Althea Technologies, located in San Diego, CA, is a contract development and manufacturing organization that specializes in cGMP manufacturing, analytical development, aseptic filling into vials & syringes, and protein delivery technology for recombinant protein and parenteral products. In a single location, Althea has the capacity to meet your early-stage and commercial requirements. Since its founding in 1998, Althea's manufacturing facilities have been inspected by the FDA in 2005, 2008, 2011, & 2012, and by over 27 different QPs. To-date, Althea's cGMP facilities have produced >250 cell banks, >150 cGMP protein & plasmid DNA lots, and >1,300 cGMP fill & finish lots. Althea has the experience, expertise, capacity, and flexibility to serve as your strategic partner for your drug development and manufacturing needs.

Centers for Clinical Research

RAVEN 1/2 CRO Partner

The Center for Clinical Research is one of the country's leading ophthalmic clinical research organizations. The Center is managed by Dr. Donald R Sanders, MD, Ph.D., one of the leading clinical and regulatory experts in the conduct of ophthalmic clinical trials. CCR is working closely with the Company to oversee, monitor and manage the RAVEN Study in Mexico and the Dominican Republic. CCR will integrate its site monitoring and data collection services to interface seamlessly with Quintiles data management and eCTD filing activities.